A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.

Jessica N PixleyTaylor SchaetzleSteven Richard Feldman

Published in: The Annals of pharmacotherapy (2022)

Roflumilast is effective and safe for the treatment of plaque psoriasis and intertriginous psoriasis. Future trials should compare its efficacy and tolerability with that of the older, clinically established topical corticosteroids. Prohibitive factors may include limited patient adherence to topical treatments and cost.

Keyphrases

coronary artery disease
physical activity
case report
clinical trial
open label
atopic dermatitis
adipose tissue
weight loss
study protocol